Last reviewed · How we verify
Dexamethasone dimenhidrinate
Dexamethasone dimenhidrinate is a Small molecule drug developed by Yeditepe University Hospital. It is currently FDA-approved. Also known as: dekort dramamin.
At a glance
| Generic name | Dexamethasone dimenhidrinate |
|---|---|
| Also known as | dekort dramamin |
| Sponsor | Yeditepe University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexamethasone dimenhidrinate CI brief — competitive landscape report
- Dexamethasone dimenhidrinate updates RSS · CI watch RSS
- Yeditepe University Hospital portfolio CI
Frequently asked questions about Dexamethasone dimenhidrinate
What is Dexamethasone dimenhidrinate?
Dexamethasone dimenhidrinate is a Small molecule drug developed by Yeditepe University Hospital.
Who makes Dexamethasone dimenhidrinate?
Dexamethasone dimenhidrinate is developed and marketed by Yeditepe University Hospital (see full Yeditepe University Hospital pipeline at /company/yeditepe-university-hospital).
Is Dexamethasone dimenhidrinate also known as anything else?
Dexamethasone dimenhidrinate is also known as dekort dramamin.
What development phase is Dexamethasone dimenhidrinate in?
Dexamethasone dimenhidrinate is FDA-approved (marketed).
Related
- Manufacturer: Yeditepe University Hospital — full pipeline
- Also known as: dekort dramamin
- Compare: Dexamethasone dimenhidrinate vs similar drugs
- Pricing: Dexamethasone dimenhidrinate cost, discount & access